The present invention relates to a portable breath gas and volatile substance analyzer comprising a breath input portion for inputting the breath into the analyzer by blowing breath, a breath delivery portion connected to the breath input portion, a breath storage portion connected to the breath delivery portion, a sensor provided in the breath storage portion for detecting the breath, and a microcontroller connected to the sensor for receiving the breath data from the sensor to analyze the gas and volatile substance data.

Methods of and devices for detecting a measurable characteristic of the gas sample. The methods and devices are able to detect a value of or a change of measurable characteristic (e.g., such as chemical concentrations), a change of chemical compositions and/or biological responses of a living organism that are induced by a stressor. The biological responses are able to include cellular stress, damage, and immune responses. The stressor is able to include an exposure to ionizing radiation. The effects of the stressors are able to be monitored in terms of changes in the chemical concentrations and chemical compositions in an exhaled breath. The chemicals are able to function as bio-markers. The chemicals that are to be monitored are able to include nitric oxide, carbon monoxide, carbon dioxide, ethane, and other molecules related to specific disease resulting from the stressor.

The disclosure pertains to a system 100 and method for collecting and measuring particles in exhaled air. The system 100 is arranged to allow for examination of the full or substantially the full volume of each exhalation of a subject.

An apparatus for collecting aerosolized respirable particles of an inhalable medicinal formulation, having a dose collection section having an air-permeable filter extending across the pathway of the aerosolized respirable particles to retain particulate material on the filter. The dose collection section having an upper filter support member and a lower filter support member, the filter being circumferentially retained between the upper and lower support members to form a filter unit; a lower body receiving the filter unit, the lower body having recesses; and a quick-release system having hooks, movable between an open position and a closed position The hooks, in the open position, can enter the recesses around the filter unit, and in the closed position, can grab the filter unit, allowing removal of the filter unit without any human contact.

A method of determining a duration of safe apnoea. Information is obtained relating to a respiratory indicator, which can include information relating to a potential respiratory equilibrium, and a duration of safe apnoea is determined from the obtained information.

Disclosed is a method for predicting a decompensation event in a patient suffering from NASH, including performing a .sup.13C methacetin breath test on a patient; calculating a PDR-peak value of the patient, based on the .sup.13C methacetin breath test; and identifying the patient as having high-risk of developing a decompensation event within 1 year from the performing of the breath test, if the PDR-peak value is at or below a predetermined threshold value; wherein the predetermined threshold value is 15%/h.

A computer-based system for receiving, analyzing, processing, managing and sending personal health information, and other information in conjunction with use of one or more personal nebulizer or vaporizing devices and personal breath analysis devices. System devices include a personal nebulizer or vaporizing unit with a mouthpiece, which may be detachable and replaceable. The mouthpiece includes an orifice through which vapor is emitted. The substance to be vaporized is contained in an ampoule inserted into the device, where the substance enters an atomization chamber where vaporization is achieved through piezoelectric transducers or atomizers providing sonic or ultrasonic vibration. The substance includes a variety of therapeutic, homeopathic, or naturopathic formulations, remedies, or serums.

This disclosure concerns an exhaled breath collection device (1000) comprising a sensor unit (100) configured to measure a biomarker in exhaled breath, a cooling device configured to reduce a temperature of exhaled breath, a mouthpiece (300) configured to direct exhaled breath towards the cooling device, and a temperature control unit. In the exhaled breath collection device of the present disclosure, the temperature control unit is configured to control the cooling device to reach a target temperature which is set appropriately to correspond with the biomarker to be analysed.

A sensor system for detecting at least one analyte in an environment includes a dehumidifier system including at least one of a condenser unit and a desiccant unit and a sensor responsive to the analyte in fluid connection with the dehumidifier system.

An electronic vaporizer system includes an anesthetic sump containing anesthetic agent, a vaporizer unit that vaporizes the anesthetic agent from the sump and delivers the vaporized agent to a patient breathing circuit, and a gas sensor configured to measure end tidal concentration of the anesthetic agent and exhalation gasses from the patient. A control system is configured to receive the measured end tidal concentration of anesthetic agent and compare the measured end tidal concentration to a desired end tidal concentration to be maintained for the patient. The vaporizer unit is then automatically controlled to deliver an amount of vaporized agent to the patient based on the comparison.